Update on InnomarPharmacy and InnomarClinic hours and availability
InnomarClinics remain open to our patients amidst coronavirus (COVID-19) concerns.
Optimizing the Patient Journey Outside the Cancer Centre
Benefits Canada |
As cancer treatments have evolved over the past decade, the use of oral take-home therapies have become more prevalent among patients in Canada. Sandra Anderson, VP of Consulting and Business Development, spoke to this paradigm shift and the new set of challenges it presents to patient care and support at Benefits Canada’s 2017 Employers Cancer Care Summit in Toronto. She highlighted that support for patients outside of the hospital setting will be critical to improving patient support.
For more information on Ms. Anderson’s presentation and the impact of oral cancer medication on the patient journey, see BenefitsCanada.com.